Ali Ozes is an accomplished scientist and entrepreneur focused on cutting-edge research and drug development with the potential to save human lives. With a Doctor of Philosophy in Molecular and Cellular Biochemistry from Indiana University Bloomington and a Bachelor of Science in Cell/Cellular and Molecular Biology from the University of California, Davis, Ali has a strong academic foundation. Ali also studied at leading accelerators such as Creative Destruction Lab and Y Combinator.

Ali has served in various roles in the biotech industry, including as a Postdoctoral Fellow at Alios Biopharma at Johnson & Johnson, a Scientist at Nalo Therapeutics, and most recently, as the Founder and CEO at Altay Therapeutics. Additionally, Ali has worked as a Biochemistry Graduate Student at Indiana University Bloomington, as well as a Junior Specialist at Buck Institute for Research on Aging and Junior Research Specialist 2 at UC Davis.

With an exceptional understanding of the biotech industry and a solid scientific background, Ali has excelled in creating and leading teams of scientists to develop cutting-edge treatments. By combining academic and industry experience, Ali's work focuses on providing effective therapies to patients globally.